Positive results for Australian company testing peptide to target glaucoma
Perth pharmaceutical company NeuroScientific Biopharmaceuticals (NSB) has announced its lead drug candidate slowed glaucoma-induced damage to the optic nerve, in ...
Tag: NeuroScientific Biopharmaceuticals